Acneiform Eruptions
Showing 1 - 25 of 31
Acne Vulgaris, Acneiform Eruptions, Skin Diseases Trial in Sacramento (Probiotic, Oral herbal powder supplement)
Not yet recruiting
- Acne Vulgaris
- +3 more
- Probiotic
- Oral herbal powder supplement
-
Sacramento, CaliforniaIntegrative Skin Science and Research
Jun 26, 2023
Acneiform Eruptions Trial in Shanghai (Cream containing JAK Inhibitor)
Recruiting
- Acneiform Eruptions
- Cream containing JAK Inhibitor
-
Shanghai, Shanghai, ChinaShanghai East Hospital
Jun 20, 2022
Acneiform Eruptions, Cancer, Treatment-Related Trial in Montreal (Doxycycline 100mg po once daily x 6 months, Isotretinoin 40 mg
Recruiting
- Acneiform Eruptions
- Cancer, Treatment-Related
- Doxycycline 100mg po once daily x 6 months
- Isotretinoin 40 mg po once daily x 6 months
-
Montreal, Quebec, CanadaJewish General Hospital
Aug 31, 2021
Acneiform Eruption Due to Chemical, Xerosis Cutis, Paronychia Trial (HT-001 2% Topical Gel, HT-001 1% Topical Gel, HT-001 0.5%
Not yet recruiting
- Acneiform Eruption Due to Chemical
- +2 more
- HT-001 2% Topical Gel
- +3 more
- (no location specified)
Dec 3, 2022
Rash Acneiform Trial in Busan (DWP708)
Recruiting
- Rash Acneiform
- DWP708
-
Busan, Korea, Republic ofDong-A University Hospital
May 22, 2022
Acneiform Eruptions Trial in Worldwide (ANB019, Placebo)
Recruiting
- Acneiform Eruptions
- ANB019
- Placebo
-
Tampa, Florida
- +17 more
Sep 8, 2021
Acne Vulgaris, Rosacea Trial in Baltimore (Timolol)
Completed
- Acne Vulgaris
- Rosacea
-
Baltimore, MarylandJohns Hopkins Dermatology Department
Nov 4, 2021
Colorectal Cancer Metastatic, Skin Toxicity Trial in Milano (Lycopene, Placebo)
Active, not recruiting
- Colorectal Cancer Metastatic
- Skin Toxicity
- Lycopene
- Placebo
-
Milano, ItalyMarco Pirovano
Sep 8, 2021
EGFRI Induced Acneiform Lesions Trial in Israel, United States (LUT014 Gel (Dose 1), LUT014 Gel (Dose 2), Placebo)
Recruiting
- EGFRI Induced Acneiform Lesions
- LUT014 Gel (Dose 1)
- +2 more
-
Glendale, California
- +15 more
Dec 29, 2022
Prevelance Of Cutaneous Disorders Among Heamatologic
Not yet recruiting
- Dermatologic Disorders With Heamatologic Malignancies Patients
- cbc ,u\s renalor hepatic function test if needed
-
Sohag, EgyptSohag university Hospital
Oct 25, 2023
EGFR Inhibitor Induced Acneiform Lesions Trial in Israel, United States (LUT014)
Completed
- EGFR Inhibitor Induced Acneiform Lesions
-
Los Angeles, California
- +5 more
Apr 5, 2022
EGFR Inhibitor-Induced Skin Rash Trial in Taipei, Taoyuan (AC-701 Topical Gel 0.3%, Placebo Gel)
Completed
- EGFR Inhibitor-Induced Skin Rash
- AC-701 Topical Gel 0.3%
- Placebo Gel
-
Taipei, Taiwan
- +1 more
Apr 25, 2022
Rare Diseases, Toxic Epidermal Necrolyses Trial in LYON cedex 03, Lyon (Filgrastim, Placebo)
Recruiting
- Rare Diseases
- Toxic Epidermal Necrolyses
- Filgrastim
- Placebo
-
LYON cedex 03, France
- +1 more
Mar 15, 2022
Sneddon-Wilkinson, Acrodermatitis Continua of Hallopeau, Pustular Psoriasis Trial run by the NIAMS (Anakinra)
Completed
- Sneddon-Wilkinson
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 5, 2021
Second Phase of Oral Challenge Test in Suspected Long-standing
Active, not recruiting
- Allergy Penicillin
-
Paris 14, FranceGroupe Hospitalier Paris Saint-Joseph
Mar 30, 2022
Ectopic Eruption of Permanent First Molars
Completed
- Failure of Tooth Eruption Associated With Tooth Impaction
- Impacted
- Self-corrected
-
Eskişehir, TurkeyEskişehir Osmangazi University
Feb 21, 2020
Acne Trial in Miami (100% cocoa powder, gelatin (Gelita))
Terminated
- Acne
- 100% cocoa powder
- gelatin (Gelita)
-
Miami, FloridaUniversity of Miami
Feb 18, 2019
Drug Reaction Trial in Bangkok (patch test)
Unknown status
- Drug Reaction
- patch test
-
Bangkok, ThailandDivision of Dermatology, Faculty of Medicine, Chulalongkorn Univ
Jun 3, 2017
Adverse Cutaneous Reaction to Alternative Medical Therapy Trial (serum interleukin 21, Complete Blood Picture, Liver function
Unknown status
- Adverse Cutaneous Reaction to Alternative Medical Therapy
- serum interleukin 21
- +5 more
- (no location specified)
May 23, 2017
Acneiform Rash Trial in Petach Tikva, (Threolone ointment, ointment Synthomycine, Aqua cream)
Completed
- Acneiform Rash
- Threolone ointment
- +2 more
-
Petach Tikva,, IsraelDavidoff Center, Rabin Medical Center, Beilinson
May 7, 2017
Cancer Trial in Belgium, Netherlands (Cetuximab (Erbitux))
Completed
- Cancer
- Cetuximab (Erbitux)
-
Antwerpen, Belgium
- +3 more
Feb 7, 2017
Toxic Epidermal Necrolysis Trial in Boston (Isotretinoin, Placebo)
Unknown status
- Toxic Epidermal Necrolysis
- Isotretinoin
- Placebo
-
Boston, MassachusettsMassachusetts General Hospital
Dec 5, 2016